Therefore, our results indicated that reduced expression of CD9 and CD81 in HCC may activate JNK signaling pathway, which promotes cancer cell proliferation via regulating the downstream genes such as Cyclin D1 and Bcl-2. This evidence concerns the gene CD9 and hepatocellular carcinoma.